Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | TERT | O14746 | 2/20 | 0.32 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.32 |
| ▸ | PIN4 | Q9Y237 | 1/20 | 0.32 |
| ▸ | BCL2 | P10415 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL44947 | 0.92 | CYP1B1 (0.38) | CYP1B1TERTPIN1PIN4 | |
| SCHEMBL17039720 | 0.90 | TERT (0.40) | TERTPIN1PIN4 | |
| SCHEMBL2858238 | 0.90 | TERT (0.40) | CYP1B1TERTPIN1PIN4BCL2 | |
| SCHEMBL3048471 | 0.89 | TERT (0.38) | CYP1B1TERTPIN1PIN4BCL2 | |
| SCHEMBL13010692 | 0.86 | CYP1B1 (0.34) | CYP1B1TERTPIN1PIN4 | |
| SCHEMBL23618213 | 0.85 | TERT (0.37) | CYP1B1TERTPIN1PIN4BCL2 | |
| SCHEMBL3731220 | 0.85 | CYP1B1 (0.35) | CYP1B1TERTPIN1PIN4 | |
| SCHEMBL17515106 | 0.83 | CYP1B1 (0.33) | CYP1B1TERT | |
| SCHEMBL17515118 | 0.82 | CYP1B1 (0.33) | CYP1B1TERT | |
| SCHEMBL17515107 | 0.81 | TERT (0.35) | CYP1B1TERTPIN1PIN4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9701784-B2 | Supramolecular polymers derived from perylene-diimides | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-07-11 | — | — | US | disclosed |
| WO-2017006325-A1 | PERYLENE DIIMIDE BASED MEMBRANE AND METHODS OF USE THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-01-12 | — | — | WO | disclosed |
| EP-3112013-A1 | PERYLENE DIIMDE BASED MEMBRANE, PREPARATION AND RECYCLING THEREOF, AND USE FOR NANOPARTICLE SEPARATION THEREOF | Yeda Research and Development Co. Ltd (IL) | 2017-01-04 | — | — | EP | disclosed |
| EP-3067354-A1 | SUPRAMOLECULAR POLYMERS DERIVED FROM PERYLENE-DIIMIDES | Yeda Research and Development Co. Ltd. (IL) | 2016-09-14 | — | — | EP | disclosed |
| US-20150240027-A1 | SUPRAMOLECULAR POLYMERS DERIVED FROM PERYLENE-DIIMIDES | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150240027-A1 | SUPRAMOLECULAR POLYMERS DERIVED FROM PERYLENE-DIIMIDES | PIN1, PARN, DDT | CYP1B1 1126/4885TERT 216/4885PIN1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.